Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; disease progression; BCG vaccine; drug therapy; administration; intravesicalBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer; TURBT, transurethral resection of the
مقالات ISI NMIBC، سرطان مثانه غیر تهاجمی تهاجمی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; urologic surgical procedures; quality improvement; checklist; surgeonsCIS, carcinoma in situ; NMIBC, nonmuscle invasive bladder cancer; TURBT, transurethral bladder tumor resection
Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; carcinoma; transitional cell; smoking; prognosis; meta-analysisBC, bladder cancer; DSS, disease specific survival; MIBC, muscle invasive bladder cancer; NMIBC, nonmuscle invasive bladder cancer; PFS, progression-free survival; R
Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; neoplasm recurrence; local; hyperthermia; induced; mitomycin; adverse effectsBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; EAU, European Association of Urology; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer
A Prospective Comparative Study of Intravesical Bacillus Calmette-Guérin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; BCG vaccine; BCG Connaught; treatment outcome; JapanBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; NMIBC, nonmuscle invasive bladder cancer; RFS, recurrence-free survival; TURBT, transurethral rese
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; gemcitabine; BCG Connaught; urinary bladder neoplasms; quality of life; risk assessmentBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CTCAE, Common Terminology Criteria for Adverse Events; GEM, gemcitabine; NMIBC, nonmuscle invasive bladder cancer
FGFR3 Mutation Analysis in Voided Urine Samples to Decrease Cystoscopies and Cost in Nonmuscle Invasive Bladder Cancer Surveillance: A Comparison of 3 Strategies
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urinary bladder neoplasms; receptor, fibroblast growth factor, type 3; cystoscopy; cost-benefit analysisCT, computerized tomography; FGFR3, fibroblast growth factor receptor 3; NMIBC, nonmuscle invasive bladder cancer; TUR, transurethral
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; mycobacterium bovis; in situ hybridization; fluorescence; treatment outcome; prognosisBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; FISH, fluorescence in situ hybridization; NMIBC, nonmuscle invasive bladder cancer; TUR
Urinary pH Is Highly Associated With Tumor Recurrence During Intravesical Mitomycin C Therapy for Nonmuscle Invasive Bladder Tumor
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urothelium; carcinoma; neoplasm recurrence; local; mitomycinBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer; TUR-BT, bladder cancer transurethral resection
Factors Affecting Response to Bacillus Calmette-Guérin Plus Interferon for Urothelial Carcinoma in Situ
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urothelium; carcinoma in situ; BCG vaccine; interferonsBCG, bacillus Calmette-Guérin; BCG-N, BCG naïve; BCG-F, BCG failure; CIS, carcinoma in situ; IFN, interferon; NMIBC, nonmuscle invasive bladder cancer
Clinical Reliability of the 2004 WHO Histological Classification System Compared With the 1973 WHO System for Ta Primary Bladder Tumors
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; urothelium; carcinoma; World Health Organization; neoplasm recurrence; localCIS, carcinoma in situ; NMIBC, nonmuscle invasive bladder cancer; PFS, progression-free survival; PUNLMP, papillary urothelial neoplasm of low malignant potential
Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder neoplasms; mycobacterium bovis; interferons; vitaminsBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; IFN-α2b, interferon α-2b; NMIBC, nonmuscle invasive bladder cancer; RDA, recommended daily allowance; Th1, T helper cell type 1; TU
Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Plus Interferon α-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic Devices
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; bladder; bladder neoplasms; BCG vaccine; interferons; prostheses and implantsAHV, artificial heart valve; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; NMIBC, nonmuscle invasive bladder cancer
Loss of Heterozygosis on IFN-α Locus is a Prognostic Indicator of Bacillus Calmette-Guerin Response for Nonmuscle Invasive Bladder Cancer
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; carcinoma; Mycobacterium bovis; loss of heterozygosity; interferon-alphaBCG, bacillus Calmette-Guerin; IFN-α, interferon-α; IL, interleukin; LOH, loss of heterozygosity; NMIBC, nonmuscle invasive bladder cancer; TUR, transurethral resecti
Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin
Keywords: NMIBC، سرطان مثانه غیر تهاجمی تهاجمی; urinary bladder; carcinoma; Mycobacterium bovis; drug therapy; hyperthermia; inducedBCG, bacillus Calmette-Guerin; EAU, European Association of Urology; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer